Ligand Pharmaceuticals (NASDAQ:LGND)
Financial specialists hoping to partake in the biotech space without going out on a limb related straightforwardly with medication advancement might need to investigate Ligand Pharmaceuticals (NASDAQ:LGND).
The organization depicts itself as a “biopharmaceutical” organization that is centered around creating or gaining advancements that help pharmaceutical organizations find and create drugs. They portray their income model as enhanced and their cost structure low and productive. Their objective for speculators is to offer a lower-hazard venture chance to take part in the guarantee of the biotech business.
Their operations concentrate on medication disclosure, early-arrange drug advancement, item transformation